Overview

Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
Phase II pilot study of a preoperative induction chemotherapy in combination with Bevacizumab followed by combined radiochemotherapy for patients with locally advanced rectal carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Austrian Breast & Colorectal Cancer Study Group
Collaborator:
Hoffmann-La Roche
Treatments:
Bevacizumab
Capecitabine
Oxaliplatin